AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Basic Medicine | Publishing Language: Chinese | Open Access

Interaction between a novel antimicrobial compound HL-J6 and Staphylococcus aureus PBP1

Mingqi XU1,2Xiangrui SHI3,4Wei LIU4Hao DUAN1Jing WEI1Yan DENG2Yue JIANG2Yingying GAO1,5( )Haibo LI2( )
Clinical Medical College, Jiamusi University, Jiamusi, Heilongjiang
Department of Microbiology and Biochemical Pharmacy, National Engineering Research Center of Immunological Products, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing
School of Pharmacy, Chongqing University, Chongqing
Institute of Immunology, Army Medical University (Third Military Medical University), Chongqing
Department of Clinical Laboratory, Banan Hospital Affiliated to Chongqing Medical University, Chongqing, China
Show Author Information

Abstract

Objective

To investigate the interaction between a novel antimicrobial compound, HL-J6, and penicillin-binding protein 1 (PBP1) of Staphylococcus aureus.

Methods

With MRSA252 genomic DNA as the template and PBP1F and PBP1R as primers, the expression plasmid pET30a-pbp1-39-608 was constructed by amplifying the target gene fragment followed by cloning into the Nde Ⅰ/Xho Ⅰ restriction sites of the pET30a vector. Then the obtained plasmids were transformed into Escherichia coli for the expression of PBP1-39-608 protein, and the product was purified by affinity chromatography. The inhibitory effect of HL-J6 on the transpeptidase activity of PBP1-39-608 was measured using peptidoglycan side chain backbone peptide, with thiol ester analog S2d as the substrate. The affinity between HL-J6 and PBP1-39-608 was detected using microscale thermophoresis (MST), and the binding interaction was confirmed by cellular thermal shift assay (CETSA). Molecular docking and dynamics simulation were performed using AutoDock Vina and Desmond software, respectively, to elucidate the binding mode of HL-J6 with the PBP1-39-608 protein and the key amino acid residues involved.

Results

The recombinant plasmid pET30a-pbp1-39-608 was successfully constructed, and PBP1-39-608 protein was produced after induction and purified, yielding a protein with an approximate molecular mass of 65×103. HL-J6 inhibited the transpeptidase activity of PBP1-39-608 in a time-dependent manner (P<0.001). The dissociation constant Kd of the binding between HL-J6 and PBP1-39-608 was 64.92 μ mol/L. Molecular docking results showed that HL-J6 bound to the active pocket of PBP1-39-608 by interacting with key residues such as ILE-348, ASN-370, THR-516 and PHE-423, with a binding score of-8.38 kcal/mol (<-5.00 kcal/mol). Dynamics simulation results indicated that the complex became stable after 50 ns.

Conclusion

HL-J6 effectively inhibits the transpeptidase activity of Staphylococcus aureus PBP1, and shows stable interaction with the protein.

CLC number: R378.11; R966; R978.19 Document code: A

References

【1】
【1】
 
 
Journal of Army Medical University
Pages 912-921

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
XU M, SHI X, LIU W, et al. Interaction between a novel antimicrobial compound HL-J6 and Staphylococcus aureus PBP1. Journal of Army Medical University, 2025, 47(9): 912-921. https://doi.org/10.16016/j.2097-0927.202501023

4

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 08 January 2025
Revised: 26 January 2025
Published: 15 May 2025
© 2025 Journal of Army Medical University

This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).